Insider activity (SEC Form 4)
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
Open-market · last 30 days:
0 buyers bought $0
0 sellers sold $0
Open-market · last 90 days:
0 buyers bought $0
2 sellers sold $2.7M
| Insider | Role | Date | Transaction | Shares | Value |
| Denton David Brock |
EVP, Secretary & Gen Counsel |
2026-08-10 |
Grant/award |
5348 |
$1.1M |
| Denton David Brock |
EVP, Secretary & Gen Counsel |
2026-08-10 |
Grant/award |
370 |
$75K |
| Denton David Brock |
EVP, Secretary & Gen Counsel |
2026-08-10 |
Tax withholding |
3479 |
$705K |
| FARMER SCOTT D |
Executive Chairman, Director |
2026-08-10 |
Grant/award |
830 |
$168K |
| FARMER SCOTT D |
Executive Chairman, Director |
2026-08-10 |
Tax withholding |
15923 |
$3.2M |
| Garula Scott |
EVP & CFO |
2026-08-10 |
Grant/award |
10695 |
$2.2M |
| Garula Scott |
EVP & CFO |
2026-08-10 |
Tax withholding |
2958 |
$600K |
| Rozakis Jim |
President & COO |
2026-08-10 |
Grant/award |
10695 |
$2.2M |
| Rozakis Jim |
President & COO |
2026-08-10 |
Grant/award |
555 |
$113K |
| Rozakis Jim |
President & COO |
2026-08-10 |
Tax withholding |
3643 |
$738K |
| Schneider Todd M. |
CEO and Director, Director |
2026-08-10 |
Grant/award |
57944 |
$11.7M |
| Schneider Todd M. |
CEO and Director, Director |
2026-08-10 |
Tax withholding |
35599 |
$7.2M |
| TYSOE RONALD W |
Director |
2026-07-22 |
Option exercise |
5048 |
$137K |
| TYSOE RONALD W |
Director |
2026-07-22 |
Tax withholding |
685 |
$137K |
| TYSOE RONALD W |
Director |
2026-07-22 |
Open-market sell |
4363 |
$872K |
| Barstad Melanie W. |
Director |
2026-07-16 |
Option exercise |
10548 |
$286K |
| Barstad Melanie W. |
Director |
2026-07-16 |
Tax withholding |
1406 |
$286K |
| Barstad Melanie W. |
Director |
2026-07-16 |
Open-market sell |
9142 |
$1.9M |
| Garula Scott |
VP & CFO |
2026-07-01 |
Tax withholding |
249 |
$42K |
| TYSOE RONALD W |
Director |
2026-04-20 |
Option exercise |
5500 |
$149K |
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.
8-K
filed 2026-08-27
confidence 85%
Item 5.02
Melanie W. Barstad notified the Company on August 26, 2026 of her decision not to stand for re-election as a director at the 2026 annual meeting, effectively departing from the board. While framed as a non-reelection rather than a resignation, this constitutes a director departure material to investors assessing board composition and governance. The filing explicitly states her decision is not due to disagreement, suggesting an orderly transition.
View raw filing on EDGAR →
8-K
filed 2026-08-03
confidence 85%
Item 5.02
Jim Rozakis was appointed President and COO effective August 1, 2026, representing a significant promotion from his prior role as Executive Vice President and COO. While the disclosure also includes compensatory arrangements (base salary of $900,000, target cash incentive of $1,125,000, target long-term incentive of $4,000,000, and one-time equity awards), the principal disclosed action is the appointment to the President role in connection with the separation of President and CEO titles. This is material as it reflects a material change in executive leadership structure.
View raw filing on EDGAR →
8-K
filed 2026-07-15
confidence 98%
Item 2.02
Cintas Corporation issued a press release on July 15, 2026 announcing its fiscal 2026 fourth quarter and full-year financial results, including revenue of $2.91 billion (Q4) and $11.26 billion (full year), operating income, net income, diluted EPS of $1.26 (Q4) and $4.91 (full year), and fiscal 2027 guidance. This is a standard earnings release disclosure under Item 2.02, furnished as Exhibit 99.
View raw filing on EDGAR →
8-K
filed 2026-06-12
confidence 95%
Item 8.01
The disclosure centers on material M&A activity: Cintas's pending acquisition of UniFirst under a Merger Agreement dated March 10, 2026. The filing reports that UniFirst shareholders voted to approve the acquisition on June 12, 2026, and that the FTC issued a Second Request on June 11, 2026, extending the HSR Act waiting period. The transaction is expected to close in the second half of 2026 subject to regulatory approvals and customary closing conditions. This is a major acquisition material to investors.
View raw filing on EDGAR →